+ More Filters

Reset Filters

Title

Funding Organization

Funding Type

Eligible Country

Deadline

Other (Select all that apply)

Show Expired Programs

Show Verified Programs

Not Verified

RPB Catalyst Award for Innovative Research Approaches for Age-Related Macular Degeneration

Research to Prevent Blindness

The Catalyst Awards for Innovative Research Approaches for Age-Related Macular Degeneration (AMD) will provide funds to researchers who are working on novel approaches to understanding or treating AMD. Ideally, at least one of the awards given will focus on a translational project – clinically relevant research that could lead to therapeutics or treatment for AMD – not yet in clinical trials.

RPB is partnering with:

American Macular Degeneration Foundation (AMDF)
Dr. H. James and Carole Free***
International Retinal Research Foundation (IRRF)

to co-fund the Catalyst Awards. One award will be given with each partner.

A wide range of applications will be considered to improve the understanding of AMD and/or to develop novel treatments for dry or wet forms of AMD. Example projects include but are not limited to AMD genetics and pathogenesis; predictive models of AMD development; new animal and in vitro models that can be used to study features in AMD; prevention of retinal degeneration; new methods of diagnosis or tracking AMD progression; metabolic factors in AMD; stem cell treatment of retinal degeneration; optogenetics; and therapeutics-delivery – or other treatment – innovations.

These Catalyst Awards are intended to provide seed money to proposed high-risk / high-gain vision science research, which is innovative, cutting-edge, and demonstrates out-of-the-box thinking. The Catalyst Award will not fund: incremental extensions of previously or currently funded research by the NEI, NIH, other government agencies, non-profits, private funders, etc. or research that does not have a direct connection to AMD.

How to Apply

Applicants must be nominated by their Department Chair. Please note: applications received without a prior nomination form will not be accepted.

AI Based Application Success Predictor

1. Alignment with RPB’s Mission

RPB’s mission is to preserve and restore vision and prevent blindness by funding research that advances understanding, treatment, or prevention of vision-threatening conditions. Grants that clearly advance this mission — including basic, translational, and clinical research into eye diseases — are competitive.RPB USA

Predictor: A proposal that explicitly ties project goals to vision loss mechanisms, treatment innovation, or prevention strategies.

2. Scientific Excellence and High-Impact Potential

RPB supports research that is scientifically rigorous and has potential for major impact in vision science. Funded awards are intended to push the field forward and have been associated with breakthroughs in areas like retinal disease, amblyopia, and glaucoma.RPB USA

Predictor: A research plan with:

clear, important questions,

strong methodology,

compelling rationale for why results will matter.

3. Track Record and Environment

For individual investigator grants (e.g., Career Development Award, Physician-Scientist Award, Stein Innovation Award), successful applicants typically have:

A solid scientific track record appropriate to career stage,

A productive research environment,

Mentorship and support from their department.RPB USA

Predictor: Evidence that the applicant has capacity, productivity, and institutional backing to complete and disseminate the research.

4. Appropriate Career Stage & Mechanism Match

RPB offers awards tailored to different career stages and research profiles, including:

Career Development Award (for promising early-career faculty),

Physician-Scientist Award (for clinician researchers),

Stein Innovation Award (for high-risk, high-gain projects),

Medical Student Eye Research Fellowship (MSERF) (for MD students),

International Research Collaborators Award (for U.S.–international partnerships).RPB USA

Predictor: Correctly choosing the grant mechanism that fits the applicant’s experience and project scope improves competitiveness.

5. Institutional and Departmental Support

For department-level grants like Unrestricted Grants or Challenge Grants, predictors of success include:

A strong existing eye research portfolio,

A mature research environment,

Leadership from department chairs committed to eye research growth,

Institutional commitment (e.g., matching funds for Challenge Grants).RPB USA+1

Predictor: Demonstrating that the department has foundation (e.g., NIH awards) and strategic vision for eye research.

6. Innovation and Novelty

Awards such as the Stein Innovation Award explicitly aim to fund cutting-edge, unconventional research that might otherwise struggle to get funded. Projects should propose high-risk, high-reward ideas with strong justification and plausible impact pathways.RPB USA

Predictor: A bold, innovative concept with clear rationale and potential to transform understanding or treatment of eye disease.

7. Clear Focus on Disease Relevance

RPB supports research across many diseases that threaten vision — from AMD, glaucoma, and retinal dystrophies to amblyopia and myopia. Funded topics often include those with a high public health burden or scientific opportunity.Newswise

Predictor: Projects that address vision-threatening conditions with significant unmet research needs are more compelling.

8. International Collaboration (When Applicable)

The International Research Collaborators Award demonstrates that internationally partnered projects can be competitive, especially when they promise geography-wide impact and knowledge exchange.RPB USA

Predictor: Thoughtful, well-structured international collaborations with clear roles and benefits.

9. Compliance With RPB Processes

RPB uses nomination and application procedures managed through department chairs (for some individual awards), with set deadlines in the spring and fall grant cycles. Complete, compliant applications with all required letters and documents are essential.RPB USA

Predictor: Timely, complete submissions that follow all instructions.

🧠 Common Weaknesses That Reduce Competitiveness

Misalignment with vision research focus: Proposals that do not clearly address eye disease mechanisms or vision outcomes are unlikely to be funded.

Poor match to award type: Applying to a mechanism that doesn’t fit the applicant’s career stage or scientific maturity.

Lack of institutional support: Especially for department grants, weak departmental engagement or inadequate infrastructure reduces chances.

Insufficient innovation or rationale: Projects that are incremental, descriptive, or poorly justified rank lower.

📌 Summary: Predictors of RPB Funding Success

Predictor	Typical Importance
Mission alignment with eye research	Essential
Scientific excellence & strong methods	High
Appropriate mechanism for career stage	High
Institutional support & environment	High
Innovation and potential impact	High (especially for Stein/Innovation)
Clear disease relevance	High
International collaboration (if relevant)	Medium
Compliance with guidelines and process	Essential

Specialties

Ophthalmology

Eligibility Requirements

This award is available to researchers from any institution of higher education in the U.S. Department chairs (including interim or acting chairs) can nominate one candidate holding a primary academic position as Assistant Professor through full Professor (MD, PhD, MD/PhD or equivalent doctoral degree). Candidates must not provide less than 5% effort for the proposed research.

Sponsor Details

Sponsor Institute/Organizations: Research to Prevent Blindness

Sponsor Type: Corporate/Non-Profit

Address: 360 Lexington Avenue, 22nd Floor New York, NY 10017

Legal & Affiliation Disclaimer

Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.

Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.

Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.

Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.

Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.

Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.

Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.

View Funding Opportunity